Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma

Dokyeong Kim,Junseong Park,Hyeon-Chun Park,Songzi Zhang,Minyoung Park,Soon A. Park,Sug Hyung Lee,Youn Soo Lee,Jae-Sung Park,Sin-Soo Jeun,Yeun-Jun Chung,Stephen Ahn
DOI: https://doi.org/10.1186/s12935-024-03225-4
IF: 6.429
2024-01-19
Cancer Cell International
Abstract:Although meningioma is the most common primary brain tumor, treatments rely on surgery and radiotherapy, and recurrent meningiomas have no standard therapeutic options due to a lack of clinically relevant research models. Current meningioma cell lines or organoids cannot reflect biological features of patient tumors since they undergo transformation along culture and consist of only tumor cells without microenvironment. We aim to establish patient-derived meningioma organoids (MNOs) preserving diverse cell types representative of the tumor microenvironment.
oncology
What problem does this paper attempt to address?